Report Id: SNS/HC/2280 | July 2022 | Region: Global | 134 Pages
Advanced Visualization Market Size was valued at USD 3.64 billion in 2022, and expected to reach USD 8.78 billion by 2030, and grow at a CAGR of 11.6% over the forecast period 2023-2030.
A contemporary diagnostic technology called advanced visualization gives the user access to a visualization platform, which fundamentally produces improved imaging and imaging procedure functionalities. The data produced can be modified to meet the needs of the doctors, which improves the quality of understanding and the efficacy of healthcare products.
The essential component of improved visualization is medical equipment with cutting-edge software that effectively displays a variety of features of living cells, enabling better illness diagnosis. A business intelligence (BI) tool is used in advanced visualization, a new generation of technology that enables users to see improved image quality. It is primarily beneficial to healthcare professionals because it enables a better knowledge of clinical problems, which leads to high-quality healthcare facilities at lower prices.
New AV Software Features, Like the Integration of Pacs & AV Tools
Data Interpretation Is Improved by Technological Advances in AV Technology
Increased Geriatric Population and Increasing Prevalence of Target Diseases
Diagnosis of Disease Must Be Effective and Early
Increasing Knowledge of the Advantages AV Tools Offer in Disease Diagnosis
Radiology-Based Diagnostic Procedures Have Limited Reimbursement Options Available
Limitations of Current AV Analysis Due to Technology
Utilizing AV Solutions with Mobile Devices
Financial Restraints in Hospitals in Mature Markets
IMPACT OF COVID-19
The COVID-19 period starting in Q2 had a detrimental impact on the market for advanced visualization. It had a profoundly unfavorable effect on the adoption of next-generation navigation and visualization technologies and radically changed the direction of surgical visualization and navigation technology. Additionally, COVID-19 began to spread at the end of 2019 and has had an impact on every area of the economy.
Due to the statewide lockdown, there was a drop in hardware and software services, and there was less of a need for enhanced visualization of chronic conditions. No geriatric or chronic disease patients visited hospitals in the first quarter of 2020. Limited manufacturing innovations in the advanced visualization market due to the COVID-19 investment shift caused by the increase in COVID-19 instances.
But the market growth of advanced visualization has been favorably impacted during the remainder of 2020. Due to the growing demand, research and development efforts on visualization systems have been doubled. The use of cutting-edge technologies for demonstrating a variety of characteristics of Lang cell efficiency has also increased. In pathological laboratories, these systems are frequently employed for a variety of clinical purposes. As a result, the market is anticipated to grow more strongly during the forecast period.
By Products & Service
The global market for advanced viewing is divided into two categories: Hardware and software, and services (continuously divided into implementation, after sales and refinement, consultation / performance, and training and learning services). Due to features such as the development of sophisticated technical software, the growing use of AV solutions in hospitals and diagnostic centers to improve operational efficiency, and the growing popularity of AV solutions due to its ease of integration into PACS, hardware and software. the segment is expected to hold the largest share in the market.
By Type of Solution
Broad-based business-oriented and independent workplace solutions form two divisions in the global market for advanced visibility. The market segment that is expected to have the largest share is expected to be business-oriented solutions based on customers and domains only. The critical market share of this category may be due to a number of factors, including the benefits provided by increased data storage capacity, data transfer capacity, multi-user interaction, faster analysis, and mid-term post-processing solutions.
By Clinical Application
With clinical use, it is divided into radiology / interventional radiology, cardiology, orthopedics, cancer, vascular, neurology, and other clinical areas (including obstetrics / gynecology, urology, pulmonary, and gastrointestinal). Due to the growing market popularity of changing processes and the inclusion of digital radiology diagnostics, the growing market acceptance of AV software, and the growing acceptance of AV solutions in the departments of radiology, the radiology / interventional radiology component is expected to hold the largest share.
Some of the major key players are as follows: Agfa HealthCare NV, Carestream Health, Inc., Fujifilm Holdings Corporation, General Electric Company, Koninklijke Philips N.V., Terarecon, Inc., Siemens AG, Visage Imaging, Inc., Qi Imaging, Toshiba Corporation.
By Products & Service
Hardware & Software
By Type of Solution
Enterprise-Wide Thin Client-Based Solutions
Standalone Workstation-Based Solutions
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
By Clinical Application
By End User
Hospitals, and Surgical Centers
Academic and Research Centers
The advanced visualization industry is predicted to be dominated by North America. The commercialization of cutting-edge diagnostic goods, the U.S. and Canada's strong R&D infrastructure, and the high prevalence of target diseases are the reasons that are fueling the expansion of the market for advanced visualization products in the area. The fastest CAGR is predicted for the Asia Pacific region due to the region's rapid expansion of healthcare infrastructure, rising public awareness of the advantages of advanced diagnostic techniques in the effective management of disease, and rising market penetration of advanced diagnostic technologies.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 3.64 Billion|
|Market Size by 2030||US$ 8.78 Billion|
|CAGR||CAGR of 11.6% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Products & Service (Hardware & Software, Services)
• By Type of Solution (Enterprise-Wide Thin Client-Based Solutions, Standalone Workstation-Based Solutions)
• By Application (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Radiotherapy (RT), Nuclear Medicine)
• By Clinical Application (Radiology/Interventional Radiology, Cardiology, Orthopedics, Oncology, Vascular, Neurology)
• By End User (Hospitals, and Surgical Centers, Imaging Centers, Academic and Research Centers)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Agfa HealthCare NV, Carestream Health, Inc., Fujifilm Holdings Corporation, General Electric Company, Koninklijke Philips N.V., Terarecon, Inc., Siemens AG, Visage Imaging, Inc., Qi Imaging, Toshiba Corporation.|
|Key Drivers||• New AV Software Features, Like the Integration of Pacs & AV Tools
• Data Interpretation Is Improved by Technological Advances in AV Technology
• Increased Geriatric Population and Increasing Prevalence of Target Diseases
|Restraints||• Radiology-Based Diagnostic Procedures Have Limited Reimbursement Options Available
• Limitations of Current AV Analysis Due to Technology
Frequently Asked Questions (FAQ) :
Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Agfa HealthCare NV, Carestream Health, Inc., Fujifilm Holdings Corporation, General Electric Company, Koninklijke Philips N.V are the key players of Advanced Visualization market
The advanced visualization industry is predicted to be dominated by North America.
Increased Geriatric Population and Increasing Prevalence of Target Diseases, Diagnosis of Disease Must Be Effective and Early are the key drivers of the Advanced Visualization market.
Ans. Advanced Visualization Market Size was valued at USD 3.27 billion in 2021.
Table of Content
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
188.8.131.52 United Kingdom
184.108.40.206 South Korea
220.127.116.11 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Advanced Visualization Market Segmentation, By Products & Service
8.1 Hardware & Software
9. Advanced Visualization Market Segmentation, By Type of Solution
9.1 Enterprise-Wide Thin Client-Based Solutions
9.2 Standalone Workstation-Based Solutions
10. Advanced Visualization Market Segmentation, By Application
10.1 Magnetic Resonance Imaging (MRI)
10.2 Computed Tomography (CT)
10.3 Positron Emission Tomography (PET)
10.5 Radiotherapy (RT)
106 Nuclear Medicine
11. Advanced Visualization Market Segmentation, By Clinical Application
11.1 Radiology/Interventional Radiology
12. Advanced Visualization Market Segmentation, By End User
12.1 Hospitals, and Surgical Centers
12.2 Imaging Centers
12.3 Academic and Research Centers
13. Regional Analysis
13.2 North America
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4.2 South Korea
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.3 South Africa
13.6 Latin America
13.6.3 Rest of Latin America
14.1 Agfa HealthCare NV
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.2 Carestream Health, Inc.
14.3 Fujifilm Holdings Corporation
14.4 General Electric Company
14.5 Koninklijke Philips N.V.
14.6 Terarecon, Inc.
14.7 Siemens AG
14.8 Visage Imaging, Inc.
14.9 Qi Imaging
14.10 Toshiba Corporation.
15.1 Competitive Benchmark
15.2 Market Share analysis
15.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.